We examined the effect on some clinical chemical assays of adding chlordiazepoxide or its two metabolites, the lactam and the N-desmethylchlordiazepoxide, to serum or urine. We also examined the effect on urinary steroid values of administering the drug for as long as 20 days. The drug, in 10-fold the expected concentrations in blood, or its metabohites, in 200-fold the expected Concentration in blood, had no significant effect on serum values for aspartate aminotransferase or alkaline phosphatase activities, values for bihirubin, albumin, or total protein, or on the electrophoretic pattern for serum proteins. Although values for urinary 17-hydroxycorticosteroids were slightly increased in addition experiments, we saw no effect of actual administration of the drug on values for either 17-hydroxycorticosteroids or 17-ketosteroids in urine.
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Methods

In vitro Studies
Serum. the drug chronically is less than 4.0 Jig/mI (13).
Values obtained for both "direct" and "indirect" bilirubin in a control serum were 1.6 and 0.5 mg/dl, respectively; no change was observed when as much as 20 jig/ml of chlordiazepoxide or its metabolites was added to the specimen before analysis.
Results
of albumin determination by the two methods are given in Table 2 . Added in vitro, the drug had no effect on the results by either method for albumin when as much as 5 g of chlordiazepoxide or its metabolites was added per milliliter of serum. The value for total protein was the same (6 g/liter) in control and test samples.
Results of protein electrophoresis are given in Table   3 .
We saw no significant variation in any of the fractions as compared with the range for eight control runs. In none of the above tests did we adduce evidence for a statistically significant interference with the assays.
We conclude that chronic dosing with chlordiazepoxide hydrochloride (10 mg three times a day for as long as 20 days) did not affect values for 17-hydroxycorticosteroids.
In vitro data do show that there is a small increase in the apparent value for urinary 17-hydroxycorticosteroids when chlordiazepoxide or its lactam or N-despiethyl metabolite is added to urine. However, this increase does not appear to be large enough to be of significance. The fact that this small increase is not corroborated by the in vivo data may be explained by intrapatient variation from day to day. There was no decrease in the values for 17-ketosteroids either in vivo or in vitro, in contrast to previously reported results.
In serum analyses-including aspartate aminotransferase, alkaline phosphatase, bilirubin, albumin, total protein, and protein electrophoresis-with use of as much as 10-fold the therapeutic blood concentrations of chlordiazepoxide and 200-fold the blood concentrations of the major metabolites, we saw no in vitro effect of the addition of chlordiazepoxide or either of its metabolites. No in vivo data for serum are presented here. These data will be included in a future study on drug interference.
